Philip L. Day

613 total citations
9 papers, 449 citations indexed

About

Philip L. Day is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Philip L. Day has authored 9 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Philip L. Day's work include HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers) and Drug-Induced Adverse Reactions (2 papers). Philip L. Day is often cited by papers focused on HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers) and Drug-Induced Adverse Reactions (2 papers). Philip L. Day collaborates with scholars based in United States, Australia and United Kingdom. Philip L. Day's co-authors include Gigi R. Diamond, Susan Zolla‐Pazner, Merrill J. Egorin, Gordon M. Dickinson, Peter Jensen, Fred M. Gordin, Charles N. Oster, Nancy G. Klimas, Naomi R. Wray and George L. Drusano and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Laboratory Investigation.

In The Last Decade

Philip L. Day

8 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip L. Day United States	6	208	157	127	98	78	9	449
John E. McKinnon United States	13	217 1.0×	129 0.8×	213 1.7×	20 0.2×	51 0.7×	34	530
Lumine Na Australia	8	145 0.7×	87 0.6×	54 0.4×	19 0.2×	31 0.4×	12	312
Dawn Bell United States	10	58 0.3×	63 0.4×	110 0.9×	17 0.2×	18 0.2×	16	293
M. Rolfe Gambia	13	179 0.9×	229 1.5×	18 0.1×	13 0.1×	148 1.9×	26	569
Karen Kaae Dodt Denmark	12	38 0.2×	52 0.3×	165 1.3×	56 0.6×	117 1.5×	15	384
Tarquin Collis United States	6	105 0.5×	57 0.4×	126 1.0×	23 0.2×	101 1.3×	7	364
Vivek Chauhan India	10	48 0.2×	37 0.2×	65 0.5×	21 0.2×	31 0.4×	48	351
Douglas Fink United Kingdom	10	102 0.5×	58 0.4×	13 0.1×	17 0.2×	63 0.8×	31	331
A. Pasquet France	8	143 0.7×	49 0.3×	17 0.1×	19 0.2×	136 1.7×	22	401
Julia Purdy United States	14	236 1.1×	100 0.6×	139 1.1×	19 0.2×	184 2.4×	23	586

Countries citing papers authored by Philip L. Day

Since Specialization

Citations

This map shows the geographic impact of Philip L. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Day more than expected).

Fields of papers citing papers by Philip L. Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip L. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Day. The network helps show where Philip L. Day may publish in the future.

Co-authorship network of co-authors of Philip L. Day

This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Day. A scholar is included among the top collaborators of Philip L. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Day. Philip L. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Brown, Marie, Warwick B. Dunn, Philip L. Day, et al.. (2010). Adapting in vitro dual perfusion of the human placenta to soluble oxygen tensions associated with normal and pre-eclamptic pregnancy. Laboratory Investigation. 91(2). 181–189. 20 indexed citations

Simberkoff, Michael S., Pamela Hartigan, John D. Hamilton, et al.. (1996). Long-Term Follow-Up of Symptomatic HIV-Infected Patients Originally Randomized to Early Versus Later Zidovudine Treatment: Report of a Veterans Affairs Cooperative Study. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(2). 142–150. 17 indexed citations

Knatterud, Genell L., Martial G. Bourassa, Carl J. Pepine, et al.. (1994). Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. Journal of the American College of Cardiology. 24(1). 11–20. 85 indexed citations

Pepine, Carl J., Nancy L. Geller, Genell L. Knatterud, et al.. (1994). The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. Journal of the American College of Cardiology. 24(1). 1–10. 68 indexed citations

Hamilton, John D., Pamela Hartigan, Michael S. Simberkoff, et al.. (1992). A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection. New England Journal of Medicine. 326(7). 437–443. 242 indexed citations

Day, Philip L., et al.. (1992). Bar coding in validating investigational drug packaging. Controlled Clinical Trials. 13(5). 384–385.

Colling, Cindy, Carol L. Fye, Philip L. Day, & Clair Haakenson. (1990). To blind…or not to blind?. Controlled Clinical Trials. 11(4). 260–260. 1 indexed citations

Imran, Ahmed & Philip L. Day. (1987). Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.. PubMed. 44(10). 2287–90. 11 indexed citations

Imran, Ahmed & Philip L. Day. (1987). Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles. American Journal of Health-System Pharmacy. 44(10). 2287–2290. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact